Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 163INDUSTRY 61NETWORK 26NIH 23OTHER_GOV 3INDIV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Plasma cell 2Lymphoid 1

Conditions

Multiple Myeloma 2Sleep Initiation and Maintenance Disorders 1Lymphoma 1Fatigue 1Depression 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × pegfilgrastim × Clear all
NCT07192770 2026-02-20

GCSF-PAIN

Ankara Etlik City Hospital

Completed
225 enrolled

Depression, Fatigue, Sleep Initiation and Maintenance Disorders

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

The Affiliated People's Hospital of Ningbo University

Phase 3 Recruiting
99 enrolled
Plasma cell

Multiple Myeloma

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

Sheba Medical Center

Phase 1/2 Unknown
24 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡